GAMMA Investing LLC Acquires 272 Shares of Masimo Corporation (NASDAQ:MASI)

GAMMA Investing LLC increased its position in shares of Masimo Corporation (NASDAQ:MASI) by 58.4% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 738 shares of the medical equipment provider’s stock after purchasing an additional 272 shares during the period. GAMMA Investing LLC’s holdings in Masimo were worth $123,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. FMR LLC boosted its holdings in Masimo by 19.8% in the fourth quarter. FMR LLC now owns 8,097,454 shares of the medical equipment provider’s stock worth $1,338,509,000 after acquiring an additional 1,340,836 shares in the last quarter. Capital Research Global Investors boosted its holdings in Masimo by 80.5% in the fourth quarter. Capital Research Global Investors now owns 2,454,975 shares of the medical equipment provider’s stock worth $405,807,000 after acquiring an additional 1,094,647 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Masimo by 119.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,735,167 shares of the medical equipment provider’s stock worth $286,823,000 after acquiring an additional 943,001 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in Masimo by 1,276.9% in the fourth quarter. Alliancebernstein L.P. now owns 947,391 shares of the medical equipment provider’s stock worth $156,604,000 after acquiring an additional 878,587 shares in the last quarter. Finally, Corient Private Wealth LLC boosted its holdings in Masimo by 8,847.1% in the fourth quarter. Corient Private Wealth LLC now owns 347,683 shares of the medical equipment provider’s stock worth $57,472,000 after acquiring an additional 343,797 shares in the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Insider Transactions at Masimo

In other Masimo news, COO Bilal Muhsin sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $163.28, for a total value of $1,632,800.00. Following the completion of the transaction, the chief operating officer directly owned 24,172 shares of the company’s stock, valued at approximately $3,946,804.16. The trade was a 29.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 9.70% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on MASI. Raymond James Financial lowered their price target on Masimo from $204.00 to $185.00 and set an “outperform” rating for the company in a report on Wednesday, May 7th. Piper Sandler reissued an “overweight” rating and issued a $200.00 price target (down previously from $215.00) on shares of Masimo in a report on Wednesday, May 7th. BTIG Research set a $193.00 price target on Masimo and gave the stock a “buy” rating in a report on Wednesday, May 7th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Thursday, April 10th. Finally, Wells Fargo & Company decreased their target price on Masimo from $205.00 to $190.00 and set an “overweight” rating for the company in a report on Wednesday, May 7th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Masimo has a consensus rating of “Moderate Buy” and a consensus price target of $191.60.

Masimo Trading Down 2.1%

Masimo stock opened at $167.67 on Friday. The company has a quick ratio of 1.62, a current ratio of 2.17 and a debt-to-equity ratio of 0.67. Masimo Corporation has a 52 week low of $101.61 and a 52 week high of $194.88. The company has a market capitalization of $9.09 billion, a price-to-earnings ratio of -18.28 and a beta of 1.19. The stock has a 50-day moving average price of $161.89 and a 200 day moving average price of $166.46.

Masimo (NASDAQ:MASI) last released its earnings results on Tuesday, May 6th. The medical equipment provider reported $1.36 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.12. Masimo had a positive return on equity of 22.56% and a negative net margin of 25.06%. The firm had revenue of $372.00 million during the quarter, compared to the consensus estimate of $367.79 million. During the same quarter in the previous year, the company posted $0.77 earnings per share. The company’s revenue was down 24.5% compared to the same quarter last year. Sell-side analysts anticipate that Masimo Corporation will post 4.1 EPS for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.